<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0191797.ref014" class="ref">
 <label class="label">14</label>
 <mixed-citation publication-type="journal" class="mixed-citation">
  <name class="name">
   <surname class="surname">Frozza</surname>
   <given-names class="given-names">COS</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Santos</surname>
   <given-names class="given-names">DA</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Rufatto</surname>
   <given-names class="given-names">LC</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Minetto</surname>
   <given-names class="given-names">L</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Scariot</surname>
   <given-names class="given-names">FJ</given-names>
  </name>, 
  <name class="name">
   <surname class="surname">Echeverrigaray</surname>
   <given-names class="given-names">S</given-names>
  </name>, 
  <etal class="etal">et al</etal>
  <article-title class="article-title">Antitumor activity of Brazilian red propolis fractions against Hep-2 cancer cell line</article-title>. 
  <source class="source">Biomed Pharmacother</source>. 
  <year class="year">2017</year>;
  <volume class="volume">91</volume>: 
  <fpage class="fpage">951</fpage>â€“
  <lpage class="lpage">963</lpage>. 
  <comment class="comment">doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biopha.2017.05.027" class="ext-link" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/j.biopha.2017.05.027</ext-link>
  </comment>
  <?supplied-pmid 28514834?>
  <pub-id pub-id-type="pmid" class="pub-id">28514834</pub-id>
 </mixed-citation>
</ref>
